Statins chronic use is associated to decreased post-ERCP acute pancreatitis incidence

Statins chronic use is associated to decreased post-ERCP acute pancreatitis incidence

Risk factors for developing PEP were: no-use of statins (p = 0.034), difficult cannulation (p = 0.003), pancreatic cannulation (p

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2017-07, Vol.17 (3), p.S77-S78
Hauptverfasser: Martinez - Moneo, Emma, Cárdenas - Jaén, Karina, Fernández Laso, Ana Belén, Bocos, Judith Millastre, Gallego, Ainara Torralba, Arriero, Silvia Martín, Almajano, Enrique Alfaro, Rayado, Guillermo García, de-Madaria, Enrique
Format: Artikel
Sprache:eng
Schlagworte:
Endocrinology & Metabolism
Gastroenterology and Hepatology
Health risk assessment
Multivariate analysis
Pancreatitis
Statins
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Risk factors for developing PEP were: no-use of statins (p = 0.034), difficult cannulation (p = 0.003), pancreatic cannulation (p
ISSN:1424-3903
1424-3911
DOI:10.1016/j.pan.2017.05.244